Insight Molecular Diagnostics Inc. Disposal Group, Including Discontinued Operation, Revenue
Insight Molecular Diagnostics Inc. (IMDX) reported Disposal Group, Including Discontinued Operation, Revenue of $421.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2023-11-09
- Insight Molecular Diagnostics Inc. disposal group, including discontinued operation, revenue for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Insight Molecular Diagnostics Inc. disposal group, including discontinued operation, revenue for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Insight Molecular Diagnostics Inc. disposal group, including discontinued operation, revenue for the quarter ending 2023-03-31 was $421.00K, a 59.67% decline year-over-year.
- Insight Molecular Diagnostics Inc. disposal group, including discontinued operation, revenue for the quarter ending 2022-12-31 was $849.00K.
- Insight Molecular Diagnostics Inc. disposal group, including discontinued operation, revenue for fiscal 2022 was $4.67M, a 15.48% decline from fiscal 2021.
- Insight Molecular Diagnostics Inc. disposal group, including discontinued operation, revenue for fiscal 2021 was $5.53M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $421.00K 10-Q · filed 2023-11-09 | $1.27M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $421.00K 10-Q · filed 2023-08-10 | $1.27M derived: sum of 3 quarters · filed 2023-08-10 | $2.22M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $421.00K 10-Q · filed 2023-05-15 | $1.27M derived: sum of 2 quarters · filed 2023-05-15 | $2.22M derived: sum of 3 quarters · filed 2023-11-09 | $4.05M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $849.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $1.80M derived: sum of 2 quarters · filed 2023-11-09 | $3.63M derived: sum of 3 quarters · filed 2023-11-09 | $4.67M 10-K · filed 2023-04-12 |
| 2022-09-30 | $950.00K 10-Q · filed 2023-11-09 | $2.78M derived: sum of 2 quarters · filed 2023-11-09 | $3.82M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.83M 10-Q · filed 2023-08-10 | $2.87M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $1.04M 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $5.53M 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |